JUN 27, 2018 06:51 AM PDT

Potential Drug May 'Freeze' Cancer Cells

WRITTEN BY: Nouran Amin

New research study is bringing hope to cancer patients undergoing the early stages of the disease, published in the journal Nature Communications, the study examines a drug compound that can put a stop onto cancer motility.

When cancer cells spread to other regions of our body that is known as metastasis which is a hallmark for deciding a cancer patient's death.

“For the vast majority of cancer—breast, prostate, lung, colon, and others—if it is detected early when it is a little lump in that organ and it has not spread, you will live. And generally, if you find it late, after it has spread throughout your body, you will die,” explains study author, Raymond Bergan, “Movement is key: the difference is black and white, night and day. If cancer cells spread throughout your body, they will take your life. We can treat it, but it will take your life.”

Although awareness on cancer is high, research was only able to focus on therapies that can kill cancer cells with no current treatment known.

However, in 2011, Bergan and colleagues began a study with chemists to seek a drug that would primarily inhibit cancer motility. They found a compound known as KBU2046 that has the potential ability to exert effects on cell motility in multiple cancers.

The study was achieved by utilizing chemical synthesis approaches to identify compounds that could alter motility in tumor cells without debilitating side effects or toxicity.

“We started off with a chemical that stopped cells from moving, then we increasingly refined that chemical until it did a perfect job of stopping the cells with no side effects,” Bergan explained.

The goal for this drug is to ultimately mange cancer in the early stages before reaching the incurable phase. However, the study has yet to expand in human testing.

“Our eventual goal is to be able to say to a woman with breast cancer: here, take this pill and your cancer won’t spread throughout your body. The same thing for patients with prostate, lung, and colon cancer,” explains Bergan.

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 14, 2019
Drug Discovery & Development
OCT 14, 2019
Common Anticonvulsant Drug May Counteract Inflammation
Sepsis is a serious medical condition that results from inflammation in the body and can cause fatal multi-organ dysfunction. The inflammation is usually t...
OCT 14, 2019
Genetics & Genomics
OCT 14, 2019
Combination Therapy Eliminates HIV From Rodent Model
In 2017, 1.8 million new cases of HIV infection were diagnosed around the world, and around 37 million people live with the virus....
OCT 14, 2019
Cell & Molecular Biology
OCT 14, 2019
Scratching a Chronic Itch
There are many potential reasons why skin might itch, but this annoying condition can significantly impact quality of life when it doesn't go away....
OCT 14, 2019
Drug Discovery & Development
OCT 14, 2019
Standard Treatment Resistance Discovered in Crohn's Disease
Researchers have mapped out more than 100,000 immune cells from biopsy samples of patients with Crohn's disease. The biopsy samples were retrieved from...
OCT 14, 2019
Drug Discovery & Development
OCT 14, 2019
New Potential Early Stage Treatment for Parkinson's
Parkinson’s Disease is the second most common neurodegenerative condition, affecting 35 million people globally. Currently without a cure, researcher...
OCT 14, 2019
Drug Discovery & Development
OCT 14, 2019
Evolutionary-Busting Cancer Drug
Researchers at the Institute of Cancer Research in London have discovered that a new type of drug that blocks treatment in cancers. The drug works by inhib...
Loading Comments...